Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick L Beijersbergen

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Mammalian life depends on two distinct pathways of DNA damage toleranceOlimpia Alessandra Buoninfante, Bas Pilzecker, Aldo Spanjaard, et al.
Molecular Cell|September 23, 2021
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gapsMariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Nucleic Acids Research|July 12, 2022
Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicineAldo Spanjaard, Ronak Shah, Daniël de Groot, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2023
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancerJoyce Y Buikhuisen, Patricia M Gomez Barila, Kate Cameron, et al.
Nature|October 4, 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancerCun Wang, Serena Vegna, Haojie Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab ResistanceKatrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
Nature Cancer|November 22, 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysisLiqin Wang, Haojie Jin, Fleur Jochems, et al.
Nature|March 28, 2014
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaChong Sun, Liqin Wang, Sidong Huang, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Mammalian life depends on two distinct pathways of DNA damage toleranceOlimpia Alessandra Buoninfante, Bas Pilzecker, Aldo Spanjaard, et al.
Molecular Cell|September 23, 2021
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gapsMariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Nucleic Acids Research|July 12, 2022
Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicineAldo Spanjaard, Ronak Shah, Daniël de Groot, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2023
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancerJoyce Y Buikhuisen, Patricia M Gomez Barila, Kate Cameron, et al.
Nature|October 4, 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancerCun Wang, Serena Vegna, Haojie Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab ResistanceKatrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
Nature Cancer|November 22, 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysisLiqin Wang, Haojie Jin, Fleur Jochems, et al.
Nature|March 28, 2014
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaChong Sun, Liqin Wang, Sidong Huang, et al.
Pageof 10